Overview

• Pakistan halted all trade with India following New Delhi's suspension of the Indus Water Treaty after the Pahalgam attack.
• Health authorities initiated emergency measures to secure pharmaceutical supplies, as 30–40% of Pakistan’s raw materials for drugs come from India.
• The Drug Regulatory Authority of Pakistan (DRAP) is seeking alternatives in China, Russia, and Europe but warns of potential critical shortages without immediate action.
• The Ministry of Health has yet to issue formal guidance on pharmaceutical imports, creating uncertainty for the industry and regulators.
• A robust black market for medicines, often of Indian origin, complicates supply-chain stability, while industry leaders have petitioned for trade exemptions for life-saving drugs.